# FaceHeart

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/faceheart

- Industry: Medical Devices & Equipment
- Headquarters: Hsinchu, Taiwan - China
- Website: www.faceheart.com
- Total disclosed funding: $7M
- Latest round: Series A (Jul 1, 2022)
- Investors on record: 4

## About

Based in Hsinchu City, Taiwan, and founded in 2018, Faceheart operates as a software development company that offers medical device development company and offers development and marketing services of heart rate detection devices and software. The founder, Bingfei Wu, is a professor of Yangming Jiaotong UniversityIn 2020, The company's patent for biological image processing and vital signs measurement device has been approved. In June 2019, it raised TWD 75 million in venture funding from new investor MediaTek Ventures. In July 2022, FaceHeart raised TWD 210 million in series A funding led by Taiwania Capital, Mega International Commercial Bank, Nenglv Asia Capital and Shangyin Investment Management Co.,Ltd.

The company offers FH Vitals™ SDK which is a mobile application providing contactless vital signs measurement solutions to its users. The software supports four types of operating systems and can be integrated with various hardware devices. It offers contactless measurement and does not require an internet connection. The solutions offered by the firm are used in healthcare, companion robots, mobile health, smart home, employee wellness, and sports technology.

The company generates revenue by developing the remote video measurement software using artificial intelligence image recognition technology.

## Funding rounds

- Series A, Jul 1, 2022, $7M — Mega International Commercial Bank, Taiwania Capital, Nenglv Asia Capital, Shangyin Investment Management Co.,Ltd.

## Investors

- Mega International Commercial Bank — Series A
- Taiwania Capital (https://capitalatlas.ai/funds/taiwania-capital) — Series A
- Nenglv Asia Capital — Series A
- Shangyin Investment Management Co.,Ltd. — Series A